Angelica Morales, Ph.D. - Publications

2014 Neuroscience 004F University of California, Los Angeles, Los Angeles, CA 
drug abuse/pharmacology

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Cao Z, McCabe M, Callas P, Cupertino RB, Ottino-González J, Murphy A, Pancholi D, Schwab N, Catherine O, Hutchison K, Cousijn J, Dagher A, Foxe JJ, Goudriaan AE, Hester R, ... ... Morales AM, et al. Recalibrating single-study effect sizes using hierarchical Bayesian models. Frontiers in Neuroimaging. 2: 1138193. PMID 38179200 DOI: 10.3389/fnimg.2023.1138193  0.321
2021 Del Giacco AC, Jones SA, Morales AM, Kliamovich D, Nagel BJ. Adolescent novelty seeking is associated with greater ventral striatal and prefrontal brain response during evaluation of risk and reward. Cognitive, Affective & Behavioral Neuroscience. PMID 34342865 DOI: 10.3758/s13415-021-00937-2  0.33
2020 Dean AC, Nurmi EL, Morales AM, Cho AK, Seaman LC, London ED. CYP2D6 genotype may moderate measures of brain structure in methamphetamine users. Addiction Biology. e12950. PMID 32767519 DOI: 10.1111/Adb.12950  0.497
2019 Chye Y, Mackey S, Gutman BA, Ching CRK, Batalla A, Blaine S, Brooks S, Caparelli EC, Cousijn J, Dagher A, Foxe JJ, Goudriaan AE, Hester R, Hutchison K, Jahanshad N, ... ... Morales A, et al. Subcortical surface morphometry in substance dependence: An ENIGMA addiction working group study. Addiction Biology. e12830. PMID 31746534 DOI: 10.1111/Adb.12830  0.513
2019 Kohno M, Morales AM, Dennis LE, McCready H, Hoffman WF, Korthuis PT. Effects of Naltrexone on Large-Scale Network Interactions in Methamphetamine Use Disorder. Frontiers in Psychiatry. 10: 603. PMID 31551824 DOI: 10.3389/Fpsyt.2019.00603  0.528
2018 Mackey S, Allgaier N, Chaarani B, Spechler P, Orr C, Bunn J, Allen NB, Alia-Klein N, Batalla A, Blaine S, Brooks S, Caparelli E, Chye YY, Cousijn J, Dagher A, ... ... Morales A, et al. Mega-Analysis of Gray Matter Volume in Substance Dependence: General and Substance-Specific Regional Effects. The American Journal of Psychiatry. appiajp201817040415. PMID 30336705 DOI: 10.1176/Appi.Ajp.2018.17040415  0.511
2018 Dean AC, Morales AM, Hellemann G, London ED. Cognitive deficit In methamphetamine users relative to childhood academic performance: Link to cortical thickness. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29704001 DOI: 10.1038/S41386-018-0065-1  0.458
2017 Okita K, Morales AM, Dean AC, Johnson MC, Lu V, Farahi J, Mandelkern MA, London ED. Striatal dopamine D1-type receptor availability: no difference from control but association with cortical thickness in methamphetamine users. Molecular Psychiatry. PMID 28894300 DOI: 10.1038/mp.2017.172  0.49
2017 Kohno M, Morales AM, Guttman Z, London ED. A neural network that links brain function, white-matter structure and risky behavior. Neuroimage. 149: 15-22. PMID 28131889 DOI: 10.1016/J.Neuroimage.2017.01.058  0.619
2016 Hofmeyr A, Monterosso J, Dean AC, Morales AM, Bilder RM, Sabb FW, London ED. Mixture models of delay discounting and smoking behavior. The American Journal of Drug and Alcohol Abuse. 1-10. PMID 27439543 DOI: 10.1080/00952990.2016.1198797  0.427
2016 Kohno M, Okita K, Morales AM, Robertson CL, Dean AC, Ghahremani DG, Sabb FW, Rawson RA, Mandelkern MA, Bilder RM, London ED. Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users. Molecular Psychiatry. PMID 26830141 DOI: 10.1038/Mp.2015.223  0.642
2016 Mackey S, Kan KJ, Chaarani B, Alia-Klein N, Batalla A, Brooks S, Cousijn J, Dagher A, de Ruiter M, Desrivieres S, Feldstein Ewing SW, Goldstein RZ, Goudriaan AE, Heitzeg MM, Hutchison K, ... ... Morales AM, et al. Genetic imaging consortium for addiction medicine: From neuroimaging to genes. Progress in Brain Research. 224: 203-23. PMID 26822360 DOI: 10.1016/Bs.Pbr.2015.07.026  0.402
2015 Kohno M, Nurmi EL, Laughlin CP, Morales AM, Gail EH, Hellemann GS, London ED. Functional Genetic Variation in Dopamine Signaling Moderates Prefrontal Cortical Activity During Risky Decision Making. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26119471 DOI: 10.1038/Npp.2015.192  0.639
2015 Morales AM, Kohno M, Robertson CL, Dean AC, Mandelkern MA, London ED. Midbrain dopamine D2/D3 receptor availability and drug craving are associated with mesocorticolimbic gray matter volume in methamphetamine users. Molecular Psychiatry. 20: 658. PMID 25993553 DOI: 10.1038/Mp.2015.59  0.607
2015 Morales AM, Kohno M, Robertson CL, Dean AC, Mandelkern MA, London ED. Gray-matter volume, midbrain dopamine D2/D3 receptors and drug craving in methamphetamine users. Molecular Psychiatry. 20: 764-71. PMID 25896164 DOI: 10.1038/Mp.2015.47  0.634
2015 Dean AC, Kohno M, Morales AM, Ghahremani DG, London ED. Denial in methamphetamine users: Associations with cognition and functional connectivity in brain. Drug and Alcohol Dependence. 151: 84-91. PMID 25840750 DOI: 10.1016/J.Drugalcdep.2015.03.004  0.616
2015 Kohno M, Ghahremani DG, Morales AM, Robertson CL, Ishibashi K, Morgan AT, Mandelkern MA, London ED. Risk-taking behavior: dopamine D2/D3 receptors, feedback, and frontolimbic activity. Cerebral Cortex (New York, N.Y. : 1991). 25: 236-45. PMID 23966584 DOI: 10.1093/Cercor/Bht218  0.622
2014 London ED, Kohno M, Morales AM, Ballard ME. Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging. Brain Research. PMID 25451127 DOI: 10.1016/J.Brainres.2014.10.044  0.706
2014 Kohno M, Morales AM, Ghahremani DG, Hellemann G, London ED. Risky decision making, prefrontal cortex, and mesocorticolimbic functional connectivity in methamphetamine dependence. Jama Psychiatry. 71: 812-20. PMID 24850532 DOI: 10.1001/Jamapsychiatry.2014.399  0.597
2014 Morales AM, Ghahremani D, Kohno M, Hellemann GS, London ED. Cigarette exposure, dependence, and craving are related to insula thickness in young adult smokers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1816-22. PMID 24584328 DOI: 10.1038/Npp.2014.48  0.568
2013 Groman SM, Morales AM, Lee B, London ED, Jentsch JD. Methamphetamine-induced increases in putamen gray matter associate with inhibitory control. Psychopharmacology. 229: 527-38. PMID 23748383 DOI: 10.1007/S00213-013-3159-9  0.445
2013 Dean AC, Groman SM, Morales AM, London ED. An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 259-74. PMID 22948978 DOI: 10.1038/npp.2012.179  0.461
2013 London ED, Mandelkern MA, Ghahremani D, Kohno M, Morales A, Robertson CL, Ishibashi K. Striatal Dopamine, Self-control and Decision-Making: Identifying Therapeutic Targets for Addiction through Brain Imaging Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 174-175. DOI: 10.1016/B978-0-12-800044-1.00154-9  0.612
2012 Morales AM, Lee B, Hellemann G, O'Neill J, London ED. Gray-matter volume in methamphetamine dependence: cigarette smoking and changes with abstinence from methamphetamine. Drug and Alcohol Dependence. 125: 230-8. PMID 22445480 DOI: 10.1016/J.Drugalcdep.2012.02.017  0.423
Show low-probability matches.